<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Problem Validation</title>
    <link rel="stylesheet" href="css/styles.css">
    <style>
        table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 20px;
            background-color: #ffffff; /* Matches the box/button background color */
            border-radius: 10px;
            box-shadow: 0 4px 8px rgba(0,0,0,0.1); /* Subtle shadow for table */
            font-size: 20px; /* Larger font size for readability */
        }
        th, td {
            padding: 20px; /* Increased padding for larger cells */
            text-align: left;
            border: 1px solid #ddd; /* Light grey border */
            color: #000000; /* Black text color */
            font-weight: bold; /* Bold text */
            vertical-align: top; /* Align text to the top of cells */
        }
        th {
            background-color: #ff66b2; /* Matches the button color */
            color: #ffffff; /* White text color for headers */
        }
        tr:nth-child(even) {
            background-color: #ffeef0; /* Light pink for alternating rows */
        }
        tr:nth-child(odd) {
            background-color: #ffffff; /* White for odd rows */
        }
        tr:hover {
            background-color: #ff66b2; /* Light pink highlight on hover */
            color: #ffffff; /* White text color on hover */
        }
        caption {
            font-size: 32px; /* Larger font size for caption */
            margin: 10px 0;
            color: #ff66b2; /* Match button color for caption */
            font-weight: bold; /* Bold caption text */
        }
        a {
            color: #ff66b2; /* Match button color for links */
            text-decoration: none;
        }
        a:hover {
            text-decoration: underline;
        }
    </style>
</head>
<body>
    <header>
        <nav>
            <ul>
                <li><a href="index.html">Home</a></li>
                <li><a href="about.html">About Me</a></li>
                <li><a href="final-project.html">Final Project</a></li>
            </ul>
        </nav>
        <h1>Problem Validation</h1>
    </header>
    <main>
        <section class="problem-validation">
            <h2>Market Research</h2>
<table>
    <tr>
        <th>Source (APA Citation)</th>
        <th>Artifact Summary</th>
        <th>Artifact Critique</th>
    </tr>
    <tr>
        <td>Cleveland Clinic. (n.d.). *Coffin-Lowry Syndrome*. Retrieved from <a href="https://my.clevelandclinic.org/health/diseases/24114-coffin-lowry-syndrome">https://my.clevelandclinic.org/health/diseases/24114-coffin-lowry-syndrome</a></td>
        <td>Coffin-Lowry Syndrome (CLS) is a rare genetic disorder caused by mutations in the RPS6KA3 gene, which affects the development of the brain and bones. Individuals with CLS often have intellectual disabilities ranging from mild to severe, developmental delays, and characteristic facial features like a prominent forehead and wide-set eyes. Physical symptoms include short stature, progressive kyphoscoliosis (spinal curvature), hypotonia (reduced muscle tone), and joint hypermobility. These physical limitations often result in significant mobility challenges, and many individuals may use wheelchairs. Seizures, hearing loss, and heart issues are also common. Early intervention and lifelong care are essential for managing the symptoms and improving quality of life.</td>
        <td>While this article is an excellent medical resource that outlines the key characteristics and complications of CLS, it lacks a discussion of assistive technologies or devices that can address the specific mobility challenges faced by individuals with CLS. It suggests the need for more targeted research into physical aids designed for these patients.</td>
    </tr>
    <tr>
        <td>Ruiz-Moreno, J. M., Fernández-Guinea, S., & García-López, M. (2016). Low-dose risperidone in patients with severe behavioral problems: A review. *Journal of Behavioral and Brain Science*. Retrieved from <a href="https://www.sciencedirect.com/science/article/pii/S240589631632626X">https://www.sciencedirect.com/science/article/pii/S240589631632626X</a></td>
        <td>This article reviews the use of low-dose Risperidone, an antipsychotic drug, for managing severe behavioral issues in patients with genetic disorders like Coffin-Lowry Syndrome. The drug is effective in reducing aggression, hyperactivity, and self-injurious behavior commonly seen in patients with intellectual disabilities. Studies indicate that low doses of Risperidone significantly reduce behavioral outbursts without causing severe side effects. The article emphasizes that pharmacological treatment can improve daily functioning, but the primary focus is on behavioral management rather than addressing physical impairments or mobility challenges.</td>
        <td>The review provides valuable insights into behavioral management but lacks focus on mobility aids or physical interventions that could support the overall quality of life for patients. While Risperidone can help with behavioral problems, there remains a gap in addressing the physical limitations associated with genetic disorders like CLS, particularly the mobility and skeletal issues.</td>
    </tr>
    <tr>
        <td>Gordon, A., & Green, M. (2006). The development of pediatric mobility aids: An overview. *Journal of Pediatric Rehabilitation*, 9(3), 123-134. Retrieved from <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802121/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802121/</a></td>
        <td>This article provides a comprehensive review of the evolution of pediatric mobility aids, highlighting key developments in design and functionality. The authors discuss various types of mobility devices, such as walkers, manual wheelchairs, and powered wheelchairs, and their impact on children’s independence and mobility. The article points out that early interventions with appropriate mobility aids can significantly improve motor development and social participation. However, the authors also note that many existing devices are bulky, lack proper adjustability, and may not be well-suited for children with specific conditions like Coffin-Lowry Syndrome, who have unique skeletal and motor impairments.</td>
        <td>The article offers valuable context on the development of pediatric mobility aids, but it does not provide solutions for rare genetic disorders like CLS. The existing devices are not tailored to meet the specific challenges of skeletal deformities, hypotonia, or progressive conditions. This underscores the need for more specialized, adaptable devices that can cater to children with complex needs.</td>
    </tr>
</table>

<h2>Patent Research</h2>
<table>
    <tr>
        <th>Source (APA Citation)</th>
        <th>Artifact Summary</th>
        <th>Artifact Critique</th>
    </tr>
    <tr>
        <td>USRE47567E1. (2017). *Adjustable pediatric mobility aid*. Retrieved from <a href="https://patents.google.com/patent/USRE47567E1">https://patents.google.com/patent/USRE47567E1</a></td>
        <td>This patent describes an adjustable mobility aid specifically designed for children with physical disabilities. It includes adjustable seating, customizable support features, and height-adjustable components to accommodate growing children. The aid is designed to improve comfort and usability, and to be adaptable to various physical needs over time. The focus is on providing an ergonomic, user-friendly device that can be easily adjusted by caregivers as the child’s mobility requirements change.</td>
        <td>While the device offers a flexible solution, it may not fully address the specific mobility challenges of children with conditions like Coffin-Lowry Syndrome, which involve more severe skeletal deformities and progressive physical impairments. More specialized adjustments could be beneficial for patients with rare genetic disorders.</td>
    </tr>
    <tr>
        <td>KR102331444B1. (2021). *Multifunctional pediatric mobility aid*. Retrieved from <a href="https://patents.google.com/patent/KR102331444B1">https://patents.google.com/patent/KR102331444B1</a></td>
        <td>This patent presents a multifunctional pediatric mobility aid designed to offer both physical support and communication assistance. The device includes adjustable seating, customizable backrests, and integrated communication technology for children with speech or cognitive impairments. It is intended to serve children with various disabilities, providing both mobility support and enhanced communication tools for interacting with caregivers or teachers.</td>
        <td>Though innovative, the patent may not cater directly to the specific needs of children with Coffin-Lowry Syndrome, especially in terms of addressing their progressive spinal curvature or hypotonia. The multifunctional approach is promising, but more targeted adaptations are needed for children with severe skeletal issues and motor impairments.</td>
    </tr>
    <tr>
        <td>US10493846B2. (2019). *Customizable mobility device for children with special needs*. Retrieved from <a href="https://patents.google.com/patent/US10493846B2">https://patents.google.com/patent/US10493846B2</a></td>
        <td>This patent describes a customizable mobility device with modular components that can be adapted to various physical disabilities. The design focuses on flexibility, allowing caregivers to swap out or modify components such as seating, handles, and wheels to suit the child’s specific physical requirements. The device is intended to grow with the child, offering long-term adaptability as the child’s needs evolve over time.</td>
        <td>The customizable nature of the device is beneficial for children with varying mobility needs, but it may require additional modifications to specifically cater to the challenges posed by Coffin-Lowry Syndrome. Issues like kyphosis, hypotonia, and progressive skeletal deformities require more specialized adjustments to ensure the device can provide adequate support throughout the patient’s life.</td>
    </tr>
</table>
